Results 271 to 277 of about 335,056 (277)

Asset Pricing Results in Option Markets: True, Spurious, or Overlooked?

Jelena Eberbach, Matthias Molnar, Philipp Schuster, Marliese Uhrig‐Homburg   +3 more
openalex   +1 more source

International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer. [PDF]

Front Public Health
Tang D, Zou X, Wei C, Zhang X.
europepmc   +1 more source

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling. [PDF]

Front Pharmacol
Xing Q, Cheng W, Wang W, Jin C, Wang H.
europepmc   +1 more source

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries. [PDF]

Cost Eff Resour Alloc
Azari S, Pourasghari H, Rezaei MA, Behzadifar M, Salehbeigi S, Rajaei S, Jafarzadeh D, Soleimanpour S, Tajdini M.   +8 more
europepmc   +1 more source

Optimal approximations for the free boundary problems of the space-time fractional Black-Scholes equations using a combined physics-informed neural network. [PDF]

Sci Rep
Song L, Tan Y, Yu F, Luo Y, Zheng J.
europepmc   +1 more source

Adaptive energy management in smart homes through fuzzy reinforcement learning and metaheuristic optimization algorithms to minimize costs. [PDF]

Sci Rep
Hamedani MMK, Jahangiri A, Mehri R, Shamim AG.   +3 more
europepmc   +1 more source

An Adaptive Evolutionary Approach to Option Pricing via Genetic Programming

, 1998
N.K. Chidambaran, Chi-Wen Jevons Lee, Joaguin R. Trigueros   +2 more
openalex   +1 more source